BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 16686844)

  • 21. Outliers in RhD membrane integration are explained by variant RH haplotypes.
    Yu X; Wagner FF; Witter B; Flegel WA
    Transfusion; 2006 Aug; 46(8):1343-51. PubMed ID: 16934070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular basis for the RhD negative phenotype in Chinese.
    Peng CT; Shih MC; Liu TC; Lin IL; Jaung SJ; Chang JG
    Int J Mol Med; 2003 Apr; 11(4):515-21. PubMed ID: 12632107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular basis of the rare gene complex, DIVa(C)-, which encodes four low-prevalence antigens in the Rh blood group system.
    Hipsky CH; Hue-Roye K; Lomas-Francis C; Huang CH; Reid ME
    Vox Sang; 2012 Feb; 102(2):167-70. PubMed ID: 21729099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. False-positive reactions of some monoclonal anti-c reagents.
    Strobel E; Bauer MF
    Transfus Med; 2009 Jun; 19(3):141-5. PubMed ID: 19566672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effective molecular RHD typing strategy for blood donations.
    Polin H; Danzer M; Hofer K; Gassner W; Gabriel C
    Transfusion; 2007 Aug; 47(8):1350-5. PubMed ID: 17655577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The genomic organization of the partial D category DVa: the presence of a new partial D associated with the DVa phenotype.
    Omi T; Takahashi J; Tsudo N; Okuda H; Iwamoto S; Tanaka M; Seno T; Tani Y; Kajii E
    Biochem Biophys Res Commun; 1999 Jan; 254(3):786-94. PubMed ID: 9920819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RHCE*cE734C allele encodes an altered c antigen and a suppressed E antigen not detected with standard reagents.
    Silvy M; Barrault A; Velliquette RW; Lomas-Francis C; Simon S; Mortelecque R; Chiaroni J; Bierling P; Noizat-Pirenne F; Bailly P; Tournamille C
    Transfusion; 2013 May; 53(5):955-61. PubMed ID: 22958092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RhCE protein variants in Southwestern Germany detected by serologic routine testing.
    Bugert P; Scharberg EA; Geisen C; von Zabern I; Flegel WA
    Transfusion; 2009 Sep; 49(9):1793-802. PubMed ID: 19453980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secondary anti-D immunization by Del red blood cells.
    Yasuda H; Ohto H; Sakuma S; Ishikawa Y
    Transfusion; 2005 Oct; 45(10):1581-4. PubMed ID: 16181208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular basis of the LOCR (Rh55) antigen.
    Coghlan G; Moulds M; Nylen E; Zelinski T
    Transfusion; 2006 Oct; 46(10):1689-92. PubMed ID: 17002624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RHD positive among C/E+ and D- blood donors in Denmark.
    Christiansen M; Sørensen BS; Grunnet N
    Transfusion; 2010 Jul; 50(7):1460-4. PubMed ID: 20456676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A D+ blood donor with a novel RHD*D-CE(5-6)-D gene variant exhibits the low-frequency antigen RH23 (D(W) ) characteristic of the partial DVa phenotype.
    Lopez GH; McGowan EC; McGrath KA; Abaca-Cleopas ME; Schoeman EM; Millard GM; O'Brien H; Liew YW; Flower RL; Hyland CA
    Transfusion; 2016 Sep; 56(9):2322-30. PubMed ID: 27390888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-D immunization by DEL red blood cells.
    Wagner T; Körmöczi GF; Buchta C; Vadon M; Lanzer G; Mayr WR; Legler TJ
    Transfusion; 2005 Apr; 45(4):520-6. PubMed ID: 15819672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Varied distribution of RhD epitopes in the Indian population.
    Kulkarni SS; Gupte SC; Vasantha K; Mohanty D; Ghosh K
    Natl Med J India; 2007; 20(4):169-71. PubMed ID: 18085120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between serology and genetics of weak D types in Denmark.
    Christiansen M; Samuelsen B; Christiansen L; Morbjerg T; Bredahl C; Grunnet N
    Transfusion; 2008 Jan; 48(1):187-93. PubMed ID: 17900277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular genetics of RH and its clinical application.
    Flegel WA
    Transfus Clin Biol; 2006; 13(1-2):4-12. PubMed ID: 16563832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rhnull syndrome: identification of a novel mutation in RHce.
    Rosa KA; Reid ME; Lomas-Francis C; Powell VI; Costa FF; Stinghen ST; Watanabe AM; Carboni EK; Baldon JP; Jucksch MM; Castilho L
    Transfusion; 2005 Nov; 45(11):1796-8. PubMed ID: 16271106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive phenotypic and molecular investigation of RhD and RhCE variants in Moroccan blood donors.
    El Housse H; El Wafi M; Ouabdelmoumene Z; Zarati F; Alid R; Nourichafi N; Bouisk K; Benajiba M; Férec C; Fichou Y; Habti N
    Blood Transfus; 2019 Mar; 17(2):151-156. PubMed ID: 30418133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serologic and molecular investigations of DAR1 (weak D Type 4.2), DAR1.2, DAR1.3, DAR2 (DARE), and DARA.
    Lejon Crottet S; Haer-Wigman L; Gowland P; Fontana S; Niederhauser C; Hustinx H
    Transfusion; 2013 Nov; 53(11 Suppl 2):3000-8. PubMed ID: 23902153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular genetics of RH.
    Flegel WA; Wagner FF
    Vox Sang; 2000; 78 Suppl 2():109-15. PubMed ID: 10938938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.